Balyasny Asset Management’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Other funds holding SLDB
SL
Balyasny Asset Management's SLDB Position: Q3 2026 in Review
Balyasny Asset Management sold out of Solid Biosciences (SLDB) in Q3 2026, closing a stake of 178,253 shares — an estimated $1.78M sold.
Balyasny Asset Management first reported a position in SLDB in Q2 2018 and held it in 11 quarters. The position peaked at $4.52M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.
- Balyasny Asset Management reported no remaining Solid Biosciences position as of Q3 2026 after selling out during the quarter.
- Balyasny Asset Management sold 178,253 Solid Biosciences shares in Q3 2026, an estimated $1.78M.
- Balyasny Asset Management first reported a position in Solid Biosciences in Q2 2018 and held it in 11 quarters.
- Balyasny Asset Management's Solid Biosciences position peaked at $4.52M in Q3 2025.
- 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.